Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710537 · ClinicalTrials.gov registry record · NA
Comparing AlloDerm and DermACELL in Breast Reconstruction
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04710537: Completed NA study, sponsored by Johns Hopkins University.
NCT04710537 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04710537, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will compare 90-day complication rates between breasts reconstructed with tissue expanders and AlloDerm vs. DermACELL, with each patient serving as her own comparator.
Interventions
- OTHER DermACELL
- OTHER AlloDerm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-10-21 |
| Est. Completion | 2022-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04710537
The ClinicalTrials.gov registry entry for NCT04710537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DermACELL is the first listed.
NCT04710537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04710537 about?
NCT04710537 is a clinical study titled "Comparing AlloDerm and DermACELL in Breast Reconstruction". This study will compare 90-day complication rates between breasts reconstructed with tissue expanders and AlloDerm vs. DermACELL, with each patient serving as her own comparator.
What is the current status of trial NCT04710537?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-10-21. Estimated completion is 2022-07-26.
What interventions are being tested in trial NCT04710537?
The interventions under investigation include: DermACELL (OTHER), AlloDerm (OTHER).
Who is sponsoring clinical trial NCT04710537?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.